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Type 1 diabetes is a chronic, autoimmune illness, involving immune rejection of the body’s insulin-producing 
pancreatic beta cells. The reduced insulin production results in a dangerous increase in blood glucose levels. 
Cell therapy is currently being explored as an attractive long-term treatment option for this disease, whereby 
pancreatic islet cells are isolated from allogeneic donors, and transplanted into affected patients. Islet 
transplantation is a minimally invasive treatment that has successfully eliminated the need for exogenous insulin 
in 50-70% of patients for 5 years (Shapiro, 2017). Limitations to this treatment include the requirement of lifelong 
immunosuppression that may lead to opportunistic infection, and the limited donor islet supply. To overcome 
these issues, we are investigating islet immunoisolation in alginate microbeads to eliminate the requirement of 
immunosuppressive drugs and to improve access to islet transplantation as a therapeutic option.  
 
Compared to conventional nozzle encapsulation processes, emulsification and internal gelation in a stirred 
vessel is a highly effective and scaleable technique for islet immunoisolation (Hoesli, 2010; Hoesli, 2012). 
However, the alginate beads produced via stirred emulsification are highly polydisperse. The objective of this 
project was to determine whether insulin-producing beta cells can be encapsulated in monodisperse alginate 
beads produced by combining internal gelation and microchannel emulsification technologies.  
 
We developed a novel microchannel emulsification 
(MCE) device (Figure 1) consisting of an alginate 
phase flowing below a hydrophobic microchannel 
plate, with a stagnant continuous oil phase above the 
plate (Markwick, 2016). Three hydrophobic and non-
toxic continuous phase fluids (light mineral oil, glyceryl 
trioleate, and 3MTM NovecTM 7500 Engineered Fluid) 
were considered in this study and evaluated based on 
their density difference with the alginate phase, as 
well as their surface tensions. Higher density difference between phases and lower continuous phase surface 
tension both resulted in facilitated droplet formation in the device. Viability assessments of encapsulated mouse 
insulinoma 6 (MIN6) cells were also conducted via live/dead staining and flow cytometry. 
 
Overall, NovecTM 7500 had the highest density difference with alginate, and the lowest surface tension, 
compared to the other fluids considered. Using this continuous phase fluid, uniform alginate beads with 
diameters as low as 1.5 mm were successfully produced with size variations < 10% and production rates of 
~100 beads per minute per channel. Preliminary assessments of MIN6 cell survival showed 82 ± 4% viability. 
Future work will seek to further reduce the minimum bead diameter that can be achieved, to improve cell 
survival, and to assess encapsulated islet function. The MCE process is a promising low-cost and high-
throughput method to encapsulate and transplant a variety of therapeutic cell types.  
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Figure 1 – MCE Encapsulation Device 
